Mizuho upgraded DepoMed Inc. (Nasdaq: DEPO) from a Neutral rating to a Buy rating sending the stock price soaring $2.34 to close at $17.85.
DepoMed upgraded
May 09, 2016 at 16:55 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.